27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Regeneron Pharmaceuticals (NASDAQ:REGN) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Regeneron Pharmaceuticals beat estimated earnings by 17.02%, reporting an EPS of $11.14 versus an estimate of $9.52.
Revenue was down $517.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23 which was followed by a 1.02% increase in the share price the next day.
Here's a look at Regeneron Pharmaceuticals's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 9.54 | 10.04 | 18.11 | 9.49 |
| EPS Actual | 9.77 | 11.49 | 23.72 | 15.37 |
| Revenue Estimate | 2.79B | 2.73B | 4.47B | 2.79B |
| Revenue Actual | 2.86B | 2.96B | 4.95B | 3.45B |
To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!